Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 22, 2020 16:07:33 GMT -5
There is no substance to this run up, other than MNKD has been undervalued for years and some margin calls... I wish day traders had a union and agreed not to sell, since short positions have to be closed... we could probably see $15, but is not happening  . They will sell and this will fizzle, but I would be happy if we at least stay above $2 from this point on until real news (UTHR TreT submission to FDA). What are you talking about? You have possible cash infusion this week with the warrant purchase and pending milestone payment. That's $23M in the coffers. You have UTHR giving a presentation on TreT early results. You have Mike doing a CHAT this week which could give more insight into MNKDs objectives! I would call that an EXCITING WEEK AHEAD. |
|
|
|
Post by mytakeonit on Jun 22, 2020 16:21:08 GMT -5
Exciting week will be more exciting if volume keeps climbing and we see $10 by Friday.
But, that's mytakeonit
|
|
|
|
Post by cretin11 on Jun 22, 2020 16:21:34 GMT -5
There is no substance to this run up, other than MNKD has been undervalued for years and some margin calls... I wish day traders had a union and agreed not to sell, since short positions have to be closed... we could probably see $15, but is not happening . They will sell and this will fizzle, but I would be happy if we at least stay above $2 from this point on until real news (UTHR TreT submission to FDA). What are you talking about? You have possible cash infusion this week with the warrant purchase and pending milestone payment. That's $23M in the coffers. You have UTHR giving a presentation on TreT early results. You have Mike doing a CHAT this week which could give more insight into MNKDs objectives! I would call that an EXCITING WEEK AHEAD. Frankly those items didn’t seem very exciting, until you used All Caps. Now it’s exciting, especially the CHAT. 🥳 |
|
|
|
Post by figglebird on Jun 22, 2020 16:23:24 GMT -5
There is no substance to this run up, other than MNKD has been undervalued for years and some margin calls... I wish day traders had a union and agreed not to sell, since short positions have to be closed... we could probably see $15, but is not happening . They will sell and this will fizzle, but I would be happy if we at least stay above $2 from this point on until real news (UTHR TreT submission to FDA). What are you talking about? You have possible cash infusion this week with the warrant purchase and pending milestone payment. That's $23M in the coffers. You have UTHR giving a presentation on TreT early results. You have Mike doing a CHAT this week which could give more insight into MNKDs objectives! I would call that an EXCITING WEEK AHEAD. You do NOT HAVE UTHR doing a presentation on tre t early results.... they are doing a presentation of data from freedom trial (tyvasso/nuebalizer) which expands patients. How this relates ultimately to tre t is one of several profoundly important questions but we have a ways to go... on the bright side fewer nvestors misunderstand this than I would have guessed. |
|
|
|
Post by babaoriley on Jun 22, 2020 17:33:32 GMT -5
What are you talking about? You have possible cash infusion this week with the warrant purchase and pending milestone payment. That's $23M in the coffers. You have UTHR giving a presentation on TreT early results. You have Mike doing a CHAT this week which could give more insight into MNKDs objectives! I would call that an EXCITING WEEK AHEAD. Frankly those items didn’t seem very exciting, until you used All Caps. Now it’s exciting, especially the CHAT. 🥳 Can’t wait for Mike’s “Chat” - going to be a markee mover. Now if I could just figure which way... |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 22, 2020 17:36:13 GMT -5
What are you talking about? You have possible cash infusion this week with the warrant purchase and pending milestone payment. That's $23M in the coffers. You have UTHR giving a presentation on TreT early results. You have Mike doing a CHAT this week which could give more insight into MNKDs objectives! I would call that an EXCITING WEEK AHEAD. You do NOT HAVE UTHR doing a presentation on tre t early results.... they are doing a presentation of data from freedom trial (tyvasso/nuebalizer) which expands patients. How this relates ultimately to tre t is one of several profoundly important questions but we have a ways to go... on the bright side fewer nvestors misunderstand this than I would have guessed. HUH?? yes I did.... |
|
|
|
Post by pat on Jun 22, 2020 18:11:46 GMT -5
There is no substance to this run up, other than MNKD has been undervalued for years and some margin calls... I wish day traders had a union and agreed not to sell, since short positions have to be closed... we could probably see $15, but is not happening . They will sell and this will fizzle, but I would be happy if we at least stay above $2 from this point on until real news (UTHR TreT submission to FDA). Obvious that we will be back to 1.50 in no time. Divided by 12 that’s 12.5 cents a share. |
|
|
|
Post by celo on Jun 22, 2020 18:41:56 GMT -5
Interesting chart pattern. So this is the third gap up this year on the yearly chart. The last two it went past and then fell back. If it goes past tomorrow, it will reach 2.35 and if it closes at or above today's close then the run may have exhausted itself. Doesn't matter because the sails are at full and the overall pattern is up with MNKD breaking the door down on the 5 year long downward dive. Where that ends, who knows. www.tradingview.com/x/02nOVmrW/ |
|
|
|
Post by radgray68 on Jun 22, 2020 19:33:13 GMT -5
This unstoppable rise is due to my arrogant selling off of trading shares and calls. I believed the volume was waning last week and........well..........you're welcome.
On a positive note, i sold some $1.50 puts for 0.12 cents a piece. That's a 10% gain in 60 days if they go unput to me. If they do, its about $1.38 a share. This little stock's a tricky one to figure out. Where is all this volume coming from?
|
|
|
|
Post by prcgorman2 on Jun 22, 2020 20:08:41 GMT -5
What’s different? Warrants expiring and this time with a change in that they look like they may be converted into shares which puts several million dollars in cash into the Mannkind bank account. Add that to what’s there already and a presumed $12.5M milestone payment from UTHR and you have the rest of 2020 expense covered (I hope). Going into 2021 we may see a material rise in Rx based on three things; Mannkind salesforce return from lockdown, positive ADA data, positive (no matter how you try to spin it otherwise) data from the Dexcom CGM trial. Add to that pediatrics and TreT moving along in spite of COVID. And last but not least, there is some mystery in play. Is it a COVID-related partnership? Is it an international marketing partner for Afrezza? Is it just that the major analyst guessed at $400M+ in revenue? Is it the unusual options action? What caused the material reduction in short interest? Nobody posting here seems to know, but we’re all suspecting something more than just the usual pump-and-dump. There seems to be a sea change in the wind pointed to by the KST and other technicals. GL2APWDs! Go MNKD! GLTALs!
|
|
|
|
Post by falconquest on Jun 22, 2020 21:13:56 GMT -5
|
|
|
|
Volume 7
Jun 23, 2020 4:25:55 GMT -5
via mobile
Post by boytroy88 on Jun 23, 2020 4:25:55 GMT -5
This is true but did the whole sector increased about as much as MNKD? If not then maybe there's something else at play here. |
|
|
|
Post by falconquest on Jun 23, 2020 4:36:36 GMT -5
This is true but did the whole sector increased about as much as MNKD? If not then maybe there's something else at play here. To answer your question, at least some of the stocks increased as much as MNKD. The one I own is up more than Mannkind so while that's good as I stated above, the reality will come when market sentiment changes. |
|
|
|
Post by veritasfiliatemporis on Jun 23, 2020 5:01:02 GMT -5
In 7 years I never saw Mannkind follow the market sentiment...little move....yes but not like this
|
|
|
|
Post by peppy on Jun 23, 2020 5:15:43 GMT -5
Here price is at $2.21. What now. $2.05 should hold any retest. $2.30 hard resistance.
Yesterday's volume, 11 million shares,
The MACD and RSI high on the daily. However if price keeps going secondary to buyers the indicators will follow.
There are targets up the wedge through resistance, if volume and buyers continue the UTHR high $3.04.
The wedge targets then, $2.30, $2.34, $3.04.
If price cuts through $2.30- $2.34 we have something here.
Wedge up.
All big IF
Some of that volume yesterday may have been delivery from the options market?
|
|
.
